FDA Law

MARCH 7, 2024

Tobolowsky & Véronique Li, Senior Medical Device Regulation Expert & David B. Moreover, DMCs are being used in trials of modest size and in the context of increased globalization of medical product development. DMC charters have also grown longer and more detailed.

Clinic 105

Clinic Provider IT Utilities 105

Today's Hospitalist

APRIL 24, 2025

Key takeaways: Admission delays from the ED can adversely affect mortality, length of stay, medical errors and quality of care. Such delays can compromise patient care by increasing mortality, medical errors and length of stay. ” Nathan Baskin, MD San Francisco VA Medical Center And they succeeded. reduction. .”

Hospital 52

Hospital Patient-Centered Patients Education 52

ABIM

JUNE 30, 2025

While some expressed approval for the recent enhancements to the LKA, others inquired whether ABIM would consider instituting a break or “year off” between five-year cycles and questioned how ABIM ensures the relevance of assessment questions to highly specialized clinical practice. Applications are due July 20, 2025.

Board-Certified 52

Board-Certified Government Community Internal Medicine 52

FDA Law

NOVEMBER 1, 2023

Lenz, Principal Medical Device Regulation Expert & Sophia R. Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Gaulkin & Jeffrey N.

Manufacturing 81

Manufacturing Hospital Healthcare Medical 81

FDA Law

DECEMBER 12, 2022

This form lists important risks, including those known or reported to be associated with the use of the LASIK laser devices based on information from clinical trials, scientific literature, and reports from patients who have undergone LASIK. After reviewing the information. Regulatory Analysis. In this context, this statement is absurd.

Manufacturing 52

Manufacturing Provider Patients IT 52

Today's Hospitalist

JUNE 7, 2025

Because many medications can cause weight gain, doctors should consider more weight-neutral alternatives. Medical societies and hospitals are weighing in on periprocedural concerns in patients taking GLP-1s who need procedures or surgeries. Key takeaways: Hospitalists will increasingly have to manage inpatients taking GLP-1s.

Hospital 65

Hospital Management Diabetes Patients 65

GeriPal

MARCH 2, 2023

2006 Transcript Eric: Welcome to the GeriPal Podcast. It’s not a controlled substance medication. Eric: So I heard gabapentin is the 10th most commonly prescribed medication in the US. I also heard that if you look at all individuals in the US, about 4% of individuals are taking one of the gabapentinoids, 10% over 65.

Patient-Centered 96

Patient-Centered IT Healthcare Medical 96